1
TÍTULO: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis  Full Text
AUTORES: Soo Yon Rhee; Jose Luis Blanco; Michael R Jordan; Jonathan Taylor; Philippe Lemey; Vici Varghese; Raph L Hamers; Silvia Bertagnolio; TobiasF. Rinke de Wit; Avelin F Aghokeng; Jan Albert; Radko Avi; Santiago Avila Rios; Pascal O Bessong; James I Brooks; Charles A B Boucher; Zabrina L Brumme; Michael P Busch; Hermann Bussmann; Marie Laure Chaix; Bum Sik Chin; Toni T D'Aquin; Cillian F De Gascun; Anne Derache; Diane Descamps; Alaka K Deshpande; Cyrille F Djoko; Susan H Eshleman; Herve Fleury; Pierre Frange; Seiichiro Fujisaki; Richard R Harrigan; Junko Hattori; Africa Holguin; Gillian M Hunt; Hiroshi Ichimura; Pontiano Kaleebu; David Katzenstein; Sasisopin Kiertiburanakul; Jerome H Kim; Sung Soon Kim; Yanpeng P Li; Irja Lutsar; Lynn Morris; Nicaise Ndembi; Kee G K Peng; Ramesh S Paranjape; Martine Peeters; Mario Poljak; Matt A Price; Manon L Ragonnet Cronin; Gustavo Reyes Teran; Morgane Rolland; Sunee Sirivichayakul; Davey M Smith; Marcelo A Soares; Vincent V Soriano; Deogratius Ssemwanga; Maja Stanojevic; Mariane A Stefani; Wataru Sugiura; Somnuek Sungkanuparph; Amilcar Tanuri; Kok Keng Tee; Hong Ha M Truong; David A M C van de Vijver; Nicole Vidal; Chunfu F Yang; Rongge G Yang; Gonzalo Yebra; John P A Ioannidis; Anne Mieke Vandamme; Robert W Shafer; ...Mais
PUBLICAÇÃO: 2015, FONTE: PLOS MEDICINE, VOLUME: 12, NÚMERO: 4
INDEXADO EM: Scopus WOS CrossRef
2
TÍTULO: Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine  Full Text
AUTORES: Theys, K; Camacho, RJ; Gomes, P; Vandamme, AM; Rhee, SY;
PUBLICAÇÃO: 2015, FONTE: CLINICAL MICROBIOLOGY AND INFECTION, VOLUME: 21, NÚMERO: 6
INDEXADO EM: Scopus WOS CrossRef: 9
3
TÍTULO: HIV-1 fitness landscape models for indinavir treatment pressure using observed evolution in longitudinal sequence data are predictive for treatment failure  Full Text
AUTORES: Raphael Z Sangeda; Kristof Theys; Gertjan Beheydt; Soo Yon Rhee; Koen Deforche; Jurgen Vercauteren; Pieter Libin; Stijn Imbrechts; Zehava Grossman; Ricardo J Camacho; Kristel Van Laethem; Alejandro Pironti; Maurizio Zazzi; Anders Sonnerborg; Francesca Incardona; Andrea De Luca; Carlo Torti; Lidia Ruiz; David A M C Van de Vijver; Robert W Shafer; Bianca Bruzzone; Eric Van Wijngaerden; Anne Mieke Vandamme ; ...Mais
PUBLICAÇÃO: 2013, FONTE: INFECTION GENETICS AND EVOLUTION, VOLUME: 19
INDEXADO EM: Scopus WOS CrossRef
4
TÍTULO: Functional conservation of HIV-1 Gag: implications for rational drug design  Full Text
AUTORES: Guangdi D Li; Jens Verheyen; Soo Yon Rhee; Arnout Voet; Anne Mieke Vandamme ; Kristof Theys;
PUBLICAÇÃO: 2013, FONTE: RETROVIROLOGY, VOLUME: 10, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef
5
TÍTULO: Estimating the individualized HIV-1 genetic barrier to resistance using a nelfinavir fitness landscape  Full Text
AUTORES: Kristof Theys; Koen Deforche; Gertjan Beheydt; Yves Moreau; Kristel van Laethem; Philippe Lemey; Ricardo J Camacho; Soo Yon Rhee; Robert W Shafer; Eric Van Wijngaerden; Anne Mieke Vandamme ;
PUBLICAÇÃO: 2010, FONTE: BMC BIOINFORMATICS, VOLUME: 11, NÚMERO: 1
INDEXADO EM: Scopus WOS CrossRef
6
TÍTULO: Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update  Full Text
AUTORES: Diane E Bennett; Ricardo J Camacho; Dan Otelea; Daniel R Kuritzkes; Herve Fleury; Mark Kiuchi; Walid Heneine; Rami Kantor; Michael R Jordan; Jonathan M Schapiro; Anne Mieke Vandamme ; Paul Sandstrom; Charles A B Boucher; David van de Vijver; Soo Yon Rhee; Tommy F Liu; Deenan Pillay; Robert W Shafer;
PUBLICAÇÃO: 2009, FONTE: PLOS ONE, VOLUME: 4, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef
7
TÍTULO: Predictive Value of HIV-1 Genotypic Resistance Test Interpretation Algorithms
AUTORES: Soo Yon Rhee; Jeffrey J Fessel; Tommy F Liu; Natalia M Marlowe; Charles M Rowland; Richard A Rode; Anne Mieke Vandamme; Kristel Van Laethem; Francoise Brun Vezinet; Vincent Calvez; Jonathan Taylor; Leo Hurley; Michael Horberg; Robert W Shafer;
PUBLICAÇÃO: 2009, FONTE: JOURNAL OF INFECTIOUS DISEASES, VOLUME: 200, NÚMERO: 3
INDEXADO EM: Scopus WOS CrossRef
8
TÍTULO: Current genotypic interpretation systems are comparable in their predictive ability and highly dependent on identifying the most active protease inhibitor
AUTORES: Rhe, SY; Fessel, WJ; Marlowe, NM; Rowland, CM; Vandamme, AM; Van Laethem, K; Brun Vezinet, F; Calvez, V; Shafer, RW;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12, NÚMERO: 5
INDEXADO EM: WOS
9
TÍTULO: Current genotypic interpretation systems are comparable in their predictive ability and highly dependent on identifying the most active protease inhibitor
AUTORES: Rhee, SY; Fessel, WJ; Marlowe, NM; Rowland, CM; Vandamme, AM; Van Laethem, K; Brun Vezinet, F; Calvez, V; Shafer, RW;
PUBLICAÇÃO: 2007, FONTE: 16th International HIV Drug Resistance Workshop in ANTIVIRAL THERAPY, VOLUME: 12
INDEXADO EM: WOS
10
TÍTULO: HIV-1 pol mutation frequency by subtype and treatment experience: extension of the HIVseq program to seven non-B subtypes
AUTORES: Rhee, SY; Kantor, R; Katzenstein, DA; Camacho, R; Morris, L; Sirivichayakul, S; Jorgensen, L; Brigido, LF; Schapiro, JM; Shafer, RW;
PUBLICAÇÃO: 2006, FONTE: AIDS, VOLUME: 20, NÚMERO: 5
INDEXADO EM: Scopus WOS CrossRef